Contact
Please use this form to send email to PR contact of this press release:
Results from an ongoing phase II study of isolated abdominal perfusion for chemoresistant and recurrent ovarian cancer
TO:
Public Relations
Medias Klinikum GmbH & Co KG
+49867791600